Genitourinary Cancers

Latest News

External validation will be assessed in cohort 2 of the AURORAX-0087A trial to improve recurrence detection for clear cell renal cell carcinoma.
Urine Glycosaminoglycan Scores Show High Sensitivity to Detect ccRCC

September 3rd 2025

External validation will be assessed in cohort 2 of the AURORAX-0087A trial to improve recurrence detection for clear cell renal cell carcinoma.

Patients with muscle-invasive bladder cancer with a positive Signatera test displayed a significant improvement in disease-free and overall survival.
ctDNA Test is Predictive of Adjuvant Atezolizumab Benefit in MIBC

August 18th 2025

Adverse reactions in the phase 3 ENVISION trial were largely mild to moderate in severity, and serious reactions occurred in 12% of those with NMIBC.
Mitomycin Exhibits Durable Responses in Recurrent, Low-Grade NMIBC

August 7th 2025

The FDA did not expand the indication to include patients with non-homologous recombination-repair gene-mutated castration-resistant prostate cancer.
FDA Accepts sNDA for Talazoparib/Enzalutamide in HRR-Mutant mCRPC

June 18th 2025

A machine learning-based approach found that evaluating multiple biomarker features may identify outcomes and treatment resistance in renal cell carcinoma.
Machine Learning Approach May Predict Outcomes in RCC

June 4th 2025

Video Series
Video Interviews
Podcasts
Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.
Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.
Latest CME Events & Activities

More News